These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3360965)

  • 1. The new monobactams: chemistry and biology.
    Sykes RB; Koster WH; Bonner DP
    J Clin Pharmacol; 1988 Feb; 28(2):113-9. PubMed ID: 3360965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of tigemonam, a novel oral monobactam.
    Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro activity of SQ 82,291, a new monobactam, in comparison with aztreonam.
    García-Rodríguez JA; García-Sánchez JE; Plata A; Trujillano I
    J Antimicrob Chemother; 1986 Mar; 17(3):303-7. PubMed ID: 3754552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigemonam, an oral monobactam.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production.
    Brown J; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro activity of tigemonam: a comparison with other antimicrobial agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam.
    Fuchs PC; Jones RN; Barry AL
    Antimicrob Agents Chemother; 1988 Mar; 32(3):346-9. PubMed ID: 3259122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of the monobactams.
    Sykes RB; Bonner DP
    Rev Infect Dis; 1985; 7 Suppl 4():S579-93. PubMed ID: 3909315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics.
    Nélet F; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1989 Aug; 24(2):173-81. PubMed ID: 2676940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae - Identification of LYS228.
    Reck F; Bermingham A; Blais J; Capka V; Cariaga T; Casarez A; Colvin R; Dean CR; Fekete A; Gong W; Growcott E; Guo H; Jones AK; Li C; Li F; Lin X; Lindvall M; Lopez S; McKenney D; Metzger L; Moser HE; Prathapam R; Rasper D; Rudewicz P; Sethuraman V; Shen X; Shaul J; Simmons RL; Tashiro K; Tang D; Tjandra M; Turner N; Uehara T; Vitt C; Whitebread S; Yifru A; Zang X; Zhu Q
    Bioorg Med Chem Lett; 2018 Feb; 28(4):748-755. PubMed ID: 29336873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramolecular nucleophilic amino attack in a monobactam: synthesis and stability of (2S,3S)- 3-[(2R)-2-amino-2-phenylacetamido]-2-methyl-4-oxo-1- azetidinesulfo nic acid.
    Indelicato JM; Fisher JW; Pasini CE
    J Pharm Sci; 1986 Mar; 75(3):304-6. PubMed ID: 3701617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
    Hellinger WC; Brewer NS
    Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
    Matsuda K; Nagashima M; Nakagawa S; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Jun; 17(6):747-53. PubMed ID: 3525497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relations of 4-fluoromethyl monobactams.
    Matsuda K; Nakagawa S; Nakano F; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1987 Jun; 19(6):753-60. PubMed ID: 3497148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.